Lerer Hippeau, founded in 2010 by Ken and Ben Lerer and Eric Hippeau, has become one of NYC’s most active seed firms — with 400+ portfolio companies across consumer, media, and B2B.

Lerer Hippeau’s seed playbook

• Early-stage focus: Pre-seed and seed, $500K–$3M checks.
• Generalist thesis: Consumer brands, B2B software, media, commerce, climate, health.
• High portfolio volume: One of the most prolific NYC seed firms.
• Operator networks: Strong alumni pipeline from portfolio companies.

Hall of fame investments

• Warby Parker (public).
• Allbirds (public).
• Casper (public).
• Buzzfeed (early).
• Everlane.
• Hinge Health — digital MSK therapy.
• Paperless Post.
• The Wing (learning story).
• Axios (media).

How Lerer Hippeau evolved

1. Early years (2010–2015): Consumer-heavy, leveraging Ken Lerer’s media network.
2. Middle period (2016–2020): Expanded to B2B SaaS and fintech as NYC ecosystem matured.
3. Current (2021–2026): Broader portfolio — climate, health, vertical SaaS, AI-adjacent B2B.

Why Lerer Hippeau matters for NYC

1. Seed-stage density: One of the few firms that can write many seed checks in a single NYC cohort.
2. Consumer expertise: Remains best-in-class for D2C / consumer seed diligence.
3. Founder support: Operating-experienced GPs; real support on brand and media.

Practical takeaway

• Founders: Lerer Hippeau is a strong fit for consumer, commerce, or operator-led B2B seeds.
• Investors: Co-investing with Lerer Hippeau is a strong signal at seed stage.
• LPs: Consistent portfolio construction makes Lerer Hippeau a reliable seed allocator.

Sources

1. Lerer Hippeau: https://www.lererhippeau.com/
2. Visible.vc NYC VC list: https://visible.vc/blog/venture-capital-firms-in-nyc/